“Nanoantibiotics”: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era

AJ Huh, YJ Kwon - Journal of controlled release, 2011 - Elsevier
Despite the fact that we live in an era of advanced and innovative technologies for
elucidating underlying mechanisms of diseases and molecularly designing new drugs …

Current insights on antifungal therapy: Novel nanotechnology approaches for drug delivery systems and new drugs from natural sources

F Sousa, D Ferreira, S Reis, P Costa - Pharmaceuticals, 2020 - mdpi.com
The high incidence of fungal infections has become a worrisome public health issue, having
been aggravated by an increase in host predisposition factors. Despite all the drugs …

Hydrogels as drug delivery systems; pros and cons

P Ghasemiyeh, S Mohammadi-Samani - Trends in Pharmaceutical …, 2019 - tips.sums.ac.ir
Hydrogels are cross-linked polymers with hydrophilic groups which enable them to absorb
large amounts of water. Hydrogel based delivery systems have been used for delivery of …

Nanoparticles and microparticles for skin drug delivery

TW Prow, JE Grice, LL Lin, R Faye, M Butler… - Advanced drug delivery …, 2011 - Elsevier
Skin is a widely used route of delivery for local and systemic drugs and is potentially a route
for their delivery as nanoparticles. The skin provides a natural physical barrier against …

[HTML][HTML] Nanoparticles: Emerging carriers for drug delivery

SR Mudshinge, AB Deore, S Patil… - Saudi pharmaceutical …, 2011 - Elsevier
The core objective of nanoparticles is to control and manipulate biomacromolecular
constructs and supramolecular assemblies that are critical to living cells in order to improve …

Development of nanoparticles for antimicrobial drug delivery

L Zhang, D Pornpattananangkul… - Current medicinal …, 2010 - ingentaconnect.com
This review focuses on the development of nanoparticle systems for antimicrobial drug
delivery. Numerous antimicrobial drugs have been prescribed to kill or inhibit the growth of …

Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products

J Pardeike, A Hommoss, RH Müller - International journal of pharmaceutics, 2009 - Elsevier
Solid lipid nanoparticles (SLN) are distinguishable from nanostructured lipid carriers (NLC)
by the composition of the solid particle matrix. Both are an alternative carrier system to …

Nanoparticles for topical drug delivery: Potential for skin cancer treatment

V Krishnan, S Mitragotri - Advanced Drug Delivery Reviews, 2020 - Elsevier
Nanoparticles offer new opportunities for the treatment of skin diseases. The barrier function
of the skin poses a significant challenge for nanoparticles to permeate into the tissue …

20 years of lipid nanoparticles (SLN & NLC): present state of development & industrial applications

RH Muller, R Shegokar… - Current drug discovery …, 2011 - ingentaconnect.com
In 1990, the lipid nanoparticles were invented in the laboratories, the first patent filings took
place in 1991. The lipid nanoparticles were developed as alternative to traditional carriers …

Recent advances in topical carriers of anti-fungal agents

A Garg, GS Sharma, AK Goyal, G Ghosh, SC Si, G Rath - Heliyon, 2020 - cell.com
Fungal skin infections are the most common global issue for skin health. Fungal infections
are often treated by topical or systemic anti-fungal therapy. Topical fungal therapy is usually …